4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-014320
EVP, Research & CSO sold 7,900 shares at $63.74 ($503,577)
- EVP, Research & CSO acquired 18,900 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-02-23 | Option exercise | +18,900 | $1.53 | $28,917 | 82,100 | D: show line 1 in the form |
| Virgin Herbert EVP, Research & CSO | 2021-02-23 | Sale | −7,900 | $63.74 | $503,577 | 74,200 | D: show line 2 in the form |
| Open-market sales · 7,900 sh · avg $63.74 · $503,577 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-02-23 | Option exercise · Stock Option (Right to Buy) | −18,900 | 353,355 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…